ISPC

iSpecimen Inc.

$0.74

-6.65%
SectorHealthcareIndustryDiagnostics & ResearchCountryUnited States

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types.

Source: Yahoo Finance
Q-Score5/ 100
Market Cap$1.9M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta0.89
AI summary

Price & performance

1M-27.8%
3M-53.8%
YTD-92.4%
1Y-97.5%
52-week range—
Beta0.89
Full chart and returns against a benchmark

Q-Score

5/ 100

Quality against peers; 50 is the peer median.

Growth14
Risk25
Performance17
Valuation14
Profitability23
Leverage13
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.9M-79.2%
Net income-$10.5M
Net margin-543.7%-409.2 pts
Historical fundamentals

Red flags in filings

5active red flags
Going-concern doubtApr 1, 2026
Material weakness in controlsApr 1, 2026
Late filing noticeMay 18, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

ISPCIndustryP/E—41.31P/S3.985.66EV/EBITDA—31.63P/B1.074.91PEG—3.59
Dividend yield0.00%
Every valuation metric